The reported scientific literature on synbiotics includes a wide range of studies carried out under different conditions. Recent human trials have used synbiotics to treat specific clinical disorders that include inflammatory bowel diseases, metabolic syndrome, diarrhea, colon cancer, irritable bowel syndrome, and kidney and liver diseases.

With an editorial from ISAPP’s Executive Science Officer Mary Ellen Sanders and science writer and health communication consultant Andreu Prados, this document contains a selection of human studies on the health benefits of synbiotics, along with advice for identifying high quality probiotics.

You can also stay up-to-date on the latest developments and opportunities in the field by following Gut Microbiota for Health-related resources and @GMFHx on Twitter.